Skip to main content

Medical nutrition therapy in dermatological diseases

Acne, hidradenitis suppurativa, and psoriasis are all influenced by obesity and metabolic and dietary factors. Clinical management should ideally include a dermatologist, endocrinologist, and nutritionist.

Read more

Editor's Choice

Obicetrapib reduces LDL–C by 30% in patients at high CV risk

Adding obicetrapib to existing lipid-lowering therapy reduces LDL cholesterol levels by 30% in patients with atherosclerotic CV disease or heterozygous familial hypercholesterolemia.

Amylin: mode of action to clinical potential

Is amylin the missing piece of the puzzle when it comes to precision diabetology? Explore amylin’s diverse physiological functions and the evolution of amylin-based therapies, from key properties to clinical significance.

SGLT2 inhibitors linked to postop euglycemic ketoacidosis risk

Long-term SGLT2 inhibitor use is associated with an increased risk for postoperative euglycemic ketoacidosis but lower risks for postoperative acute kidney injury and mortality.

Diabetic foot in the context of rheumatic diseases

Understand the pathogenic mechanisms underlying diabetic foot development in patients with rheumatic diseases, the impact of chronic inflammation and drug therapy, and current diagnostic approaches, treatment strategies, and preventive measures.

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Episode 19: GLP-1 medicines - past, present, and future

From diabetes to obesity and beyond

In 2005 the US FDA approved the first GLP-1 medicine for type 2 diabetes, marking the start of a remarkable journey that goes beyond the stimulation of insulin secretion.

Prof. Daniel Drucker gives us a fascinating insight into the early work on GLP-1 and discusses how these medicines are impacting the lives of people with diabetes and obesity. He covers what's known about how they work, treatment duration, side effects, and the role of bariatric surgery, plus what's in the pipeline in terms of drug development and the indications that GLP-1 medicines may be used to treat in the future.

Prof. Daniel Drucker
Listen now
Podcast

Using CGM to optimize type 2 diabetes management with non-intensive insulin treatment in primary care

With the growing importance of primary care in diabetes, this podcast discusses the evidence on continuous glucose monitoring (CGM) use, the role of primary healthcare, and practical tips for interpreting the ambulatory glucose profile (AGP) report. 

Supported by:
  • Abbott Diabetes Care
Prof. Samuel Seidu
Developed by: Adis
Listen now
Podcast

Case Studies

Unexpected cause of pseudoascites in an adult with type 1 diabetes

A 64-year-old man with type 1 diabetes presented with notable abdominal swelling over the previous 3 months. Investigations led to a diagnosis of pseudoascites and celiac disease was identified as the cause.

Skin infection or lymphoma in a woman with type 2 diabetes?

Cutaneous lymphoma should be considered in patients with long-standing, poorly controlled type 2 diabetes and chronic non-healing skin lesions. In this case, primary cutaneous B-cell lymphoma was misdiagnosed as a skin infection.

Colonic ischemia associated with a GLP-1 RA

Although it seems to be a rare complication, there should be a high index of suspicion for colonic ischemia in patients taking a GLP-1 receptor agonist who present with abdominal pain.

Keynote series | Spotlight on managing health in obesity

Obesity is a major contributor to cardiorenal metabolic disease, but its impact extends throughout the body. Understand how obesity can affect other organ systems and impact treatment, and whether weight-loss measures improve outcomes.

Prof. Eva L. Feldman
Prof. Jonette Keri
Developed by: Springer Medicine
Watch now
Video

Current Reviews

The Role of Omics Techniques in Diabetic Wound Healing: Recent Insights into the Application of Single-Cell RNA Sequencing, Bulk RNA Sequencing, Spatial Transcriptomics, and Proteomics

Diabetic foot ulcers (DFUs) are a devastating complication of diabetes mellitus (DM) that affect millions of people worldwide every year. They have a long-term impact on patients' quality of life and pose a significant challenge for both patients …

Topical insulin as a novel treatment for persistent epithelial defects and other ocular surface disorders: a systematic review

Despite all the advances in ophthalmic care, several of these surface disorders are challenging and may present with significant visual impairments that complicate their management. The spectrum may involve persistent epithelial defects (PEDs) …

Rationality over convenience: The CDSCO’s regulatory ban on irrational antidiabetic fixed-dose combinations in India and its clinical-pharmacological imperatives

India has emerged as one of the largest global markets for antidiabetic medications, with over 100 million individuals living with diabetes [ 1 , 2 ]. As the prevalence of chronic diseases continues to rise, the use of fixed-dose combinations …

How early can we detect diabetic retinopathy? A narrative review of imaging tools for structural assessment of the retina

Diabetes mellitus (DM) is a chronic d isease that occurs when the pancreas does not produce enough insulin, or when the body cannot effectively use the insulin it produces [ 1 ], and is associated with many ocular complications, such as cataract [ …

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more

CME & eLearning

Videos | Case Scenarios | Infographics (Link opens in a new window)

1.0 AMA PRA Category 1 Credit(s)

Refine the application of CGM technology in primary care to enhance the management of type 2 diabetes. Benefit from key updates and experiential learning using CGM devices, and practice your clinical decision-making skills.

Supported by:
  • Abbott
Developed by: Springer Healthcare IME

Vodcasts | Case Scenarios (Link opens in a new window)

Expert guidance on the multidisciplinary approach to identifying and managing chronic kidney disease in patients with type 2 diabetes, plus patient scenarios to assist your decision-making and put the latest clinical guidelines into context.

This program is not available to users in the UK and US.

Supported by:
  • Novo Nordisk A/S
Developed by: Springer Healthcare IME

News | Expert Reviews | Cases (Link opens in a new window)

Treating children with hormone disorders is complex and requires tailored management. To help you provide the most effective care, we deliver resources covering adrenal, thyroid, pituitary, growth, and puberty disorders, obesity, and diabetes.

Supported by:
  • Merck Healthcare KGaA, Darmstadt, Germany
Developed by: Springer Healthcare IME

Further Reading

Impact of Empagliflozin on Cardiovascular Outcomes and Renal Function in Patients with Obesity and Type 2 Diabetes: A Retrospective Cohort Study

Type 2 diabetes mellitus (T2DM) is an escalating global health concern, with its prevalence largely driven by the concurrent rise in obesity [ 1 , 2 ]. As reported by the International Diabetes Federation, diabetes affected approximately 463 …

Effect of lipotoxic hepatocyte-derived extracellular vesicles in pancreas inflammation: essential role of macrophage TLR4 in beta cell functionality

  • Open Access
  • Insulins
  • Original Research

The association between type 2 diabetes and metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD), is increasing in clinical practice, especially in Western countries. Both …

Macitentan and Tadalafil Combination Therapy in Patients with Pulmonary Arterial Hypertension and Cardiovascular Comorbidities: Real-World Evidence from OPUS and OrPHeUS

Patients with pulmonary arterial hypertension (PAH) in clinical practice often present with risk factors associated with cardiovascular diseases [ 1 – 7 ], defined in the 2022 European Society of Cardiology/European Respiratory Society (ESC/ERS) …

Glycaemic and Weight Control in People Aged 65 or Younger Newly Diagnosed with Type 2 Diabetes in Spain: Insights from the PRIORITY-T2D Study

Guidelines from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) recommend a holistic person-centred approach to type 2 diabetes (T2D) management, with goals of care being to prevent …

Related topics

Medical nutrition therapy in dermatological diseases

Acne, hidradenitis suppurativa, and psoriasis are all influenced by obesity and metabolic and dietary factors. Clinical management should ideally include a dermatologist, endocrinologist, and nutritionist.

Read more

Amylin: mode of action to clinical potential

Is amylin the missing piece of the puzzle when it comes to precision diabetology? Explore amylin’s diverse physiological functions and the evolution of amylin-based therapies, from key properties to clinical significance.

Read more

Diabetic foot in the context of rheumatic diseases

Understand the pathogenic mechanisms underlying diabetic foot development in patients with rheumatic diseases, the impact of chronic inflammation and drug therapy, and current diagnostic approaches, treatment strategies, and preventive measures.

Read more

Focus on insulin icodec

A thorough overview of the safety and efficacy of once-weekly basal insulin icodec in type 1 and 2 diabetes, covering pharmacology, pharmacokinetics, adverse effects, drug interactions, and dose recommendations.

Read more